| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |